Azacitidine and thrombocytopenia Patient Reports February 11, 2012

Azacitidine Side Effects Report #4758508-5
Azacitidine side effect was reported by a Physician from GERMANY on Aug 11, 2005. Male patient, 79 years of age, weighting 189.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: condition aggravated, myelodysplastic syndrome, myelofibrosis, thrombocytopenia. Azacitidine dosage: (150 MG, [~75 MG/M2] ONCE DAILY), SUBCUTANEOUS. During the same period patient was treated with ZOFRAN. Patient recovered.

Azacitidine Side Effects Report #5167457-2
Azacitidine side effect was reported by a Physician from AUSTRALIA on Nov 16, 2006. Male patient, 71 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: hyphaema, thrombocytopenia, vision blurred. Azacitidine dosage: 75 MG/M2 (DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with PREDNEFRINTE, TRANEXAMIC ACID, DICLOFENAC EC, VOLTAREN SUPPOSITORY, RABEPRAZOLE, COLOXYL WITH SENNA, DUPHALAC, FUROSEMIDE. Patient recovered.

Azacitidine Side Effects Report #4551280-3
Azacitidine side effect was reported by a Physician from on Jan 11, 2005. Male patient, 64 years of age, weighting 273.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: anaemia, chest pain , haemolysis, renal failure acute, thrombocytopenia, transfusion reaction, upper gastrointestinal haemorrhage. Azacitidine dosage: 75 MG/M2 DAILY X 7 SUBCUTANEOUS. During the same period patient was treated with DIALYSIS, PLATELET AND PRBC TRANSFUSION, MASK CPAP. Patient was hospitalized. Patient died on 01/10/2005.

Azacitidine Side Effects Report #5357137-2
Azacitidine side effect was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Male patient, 59 years of age, was diagnosed with myelodysplastic syndrome, non-hodgkin's lymphoma and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: thrombocytopenia. Azacitidine dosage: 100MG EVERY DAY IV. Patient was hospitalized. Patient recovered.


Azacitidine Side Effects Report #6071845-X
Azacitidine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2009. Female patient, weighting 101.4 lb, was diagnosed with myelodysplastic syndrome, infection , nausea , insomnia, pain  and was treated with Azacitidine. After drug was administered, patient experienced the following side effects: haemorrhage, hypotension, peritoneal haemorrhage, post procedural haemorrhage, thrombocytopenia. Azacitidine dosage: unknown. During the same period patient was treated with DIFLUCAN, POTASSIUM PHOSPHATES, PHENERGAN, AMBIEN, MAGNESIUM SULPHATE, OXYCODONE. Patient was hospitalized. Patient recovered.